Sorting nexin 27 regulates Aβ production through modulating γ-secretase activity.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Patients with Down syndrome (DS) invariably develop Alzheimer's disease (AD) pathology.
• MicroRNA-155 overexpression in DS reduces SNX27, impairing synaptic function.
• SNX27 is a key membrane trafficking protein.

Purpose of the Study:

• To investigate the role of SNX27 in regulating beta-amyloid (Aβ) generation.
• To elucidate the molecular mechanism linking SNX27 to Aβ production and γ-secretase activity.
• To establish a molecular link between Down syndrome, Alzheimer's disease, and SNX27.

Main Methods:

• RNA interference (RNAi) to downregulate SNX27.
• Overexpression of full-length SNX27 and SNX27ΔPDZ.
• Genetic deletion of Snx27 in a mouse model.
• Adeno-associated viral (AAV) vector delivery of SNX27 in a transgenic AD mouse model.
• Co-immunoprecipitation to study SNX27 interaction with presenilin 1.

Main Results:

• Downregulation of SNX27 increased Aβ production.
• Overexpression of SNX27 reversed RNAi-mediated Aβ elevation.
• Genetic deletion of Snx27 promoted Aβ production and neuronal loss.
• SNX27 overexpression reduced hippocampal Aβ levels in AD mouse models.
• SNX27 associates with presenilin 1, dissociating the γ-secretase complex and decreasing its activity.

Conclusions:

• SNX27 regulates Aβ generation by modulating γ-secretase activity.
• Reduced SNX27 levels contribute to Aβ-dependent pathogenesis in DS and AD.
• SNX27 represents a potential therapeutic target for AD and DS-related neurodegeneration.